MBI News

The American Society of Addiction Medicine named Scott Teitelbaum, M.D., UF Health Florida Recovery Center medical director, winner of its prestigious award.

Drs. DeKosky, Jaffee and Bauer's JAMA editorial addresses long-term mortality in NFL football players.

A study by Dr. Yulia Orlova published in JAMA Neurology supports the safety of combining two medications (triptans and SSRIs or SNRIs) to treat both migraines and depression.

The spring edition of The Brainstorm features info on the MBI's outreach and education endeavors, links to news articles featuring MBI members and more.

Chair of neurology Michael S. Okun, M.D., has been named the recipient of the 2018 American Society for Experimental Neurotherapeutics Presidential Award.

Congratulations to the first MBI Training Enhancement Opportunity award winners: Abbi Hernandez, Aprinda Indahlastari and Aline C. Oliveira.

Barbara Sperrazza was a dietitian and diabetes educator who had the warmest smile and loved to help people. She lost her ability to read, write, speak and eventually swallow due to frontotemporal dementia.

Join MBI director Dr. Todd Golde at noon Wednesday, Feb. 7 for this Science AAAS webinar.

Visit Drs. Todd Golde and Brenda Moore's Reddit Science AMA from Jan. 31, where they answered questions about the future of Alzheimer's research.

Dr. Gozal kicks off this new lecture series with a discussion about the neurocognitive consequences of sleep apnea and the lessons learned from animal models and children.